{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:42:34Z","timestamp":1773816154548,"version":"3.50.1"},"reference-count":79,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Approximately 795,000 people experience new or recurrent strokes in the United States each year; between 10 to 20% of these are spontaneous intracerebral hemorrhages (ICH). Uncontrolled hypertension is not only the most common cause of ICH but also a major risk factor for hematoma expansion. Resistant hypertension, defined as persistently elevated blood pressure despite the use of three or more antihypertensives of different classes, is common in patients with ICH. A long-acting calcium channel blocker, angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB), and a thiazide diuretic are generally considered the mainstay for the treatment of resistant hypertension. However, due to the risk of hyponatremia and worsening cerebral edema, thiazide diuretics should be avoided during the first few weeks of ICH. Recent evidence supports the use of a mineralocorticoid receptor antagonist. While resistant hypertension may be idiopathic, a workup of secondary causes should be pursued. Adequate and timely control of elevated blood pressure remains one of the main cornerstones of treatment in patients with ICH. Previous studies have revealed that resistant hypertension in patients with ICH is associated with longer ICU stays, a higher risk of recurrent stroke, and can contribute to renal, cardiac, and neurologic complications. This emphasizes the need for early initiation of oral antihypertensives and adequate blood pressure control at hospital discharge. Landmark studies have shown that early lowering of SBP to 130\u2013150 mm Hg with smooth, sustained BP control is safe and may improve functional outcomes in patients with mild to moderate ICH. After initiating oral antihypertensives with a calcium channel blocker, an ACEi or ARB beta-blocker, and a mineralocorticoid receptor antagonist to maximally tolerated doses, the next line of antihypertensive treatment should be tailored to the patient\u2019s co-morbidities, and may include a beta-blocker, central alpha agonist, hydralazine, and minoxidil. In this review, we discuss the epidemiology of resistant hypertension in ICH and its molecular basis, diagnostic workup, and acute and long-term treatment. We present novel mechanisms implicated in hypertensive ICH, including ferroptosis, neuroinflammation, the CNS\u2013gut microbiome axis, and novel therapeutics. We also propose a simple algorithm for the optimal pharmacological management of resistant hypertension in ICH.<\/jats:p>","DOI":"10.3390\/ijms27062716","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:35:57Z","timestamp":1773740157000},"page":"2716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage"],"prefix":"10.3390","volume":"27","author":[{"given":"Michelle","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Neurology, University of California Irvine, Orange, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sookyung","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California Irvine, Orange, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"King","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of California Irvine, Orange, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wengui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California Irvine, Orange, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Riad","family":"Ramadan","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California Irvine, Orange, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: A report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref_2","unstructured":"Unnithan, A.K.A., and Das, J.M. (2026, March 11). Hemorrhagic Stroke Overview, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559173\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/CON.0000000000000831","article-title":"Epidemiology and primary prevention of stroke","volume":"26","author":"Furie","year":"2020","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Caplan, L.R. (2016). Caplan\u2019s Stroke, Cambridge University Press.","DOI":"10.1093\/med\/9780190497255.001.0001"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/svn-2016-000047","article-title":"Current management of spontaneous intracerebral haemorrhage","volume":"2","author":"Dastur","year":"2017","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, Z., You, M., Long, C., Bi, R., Xu, H., He, Q., and Hu, B. (2020). Hematoma expansion in intracerebral hemorrhage: An update on prediction and treatment. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00702"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12028-020-00951-1","article-title":"Early initiation of oral antihypertensives reduces intensive care unit stay and hospital cost for patients with hypertensive intracerebral hemorrhage","volume":"32","author":"Zhu","year":"2020","journal-title":"Neurocrit. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1161\/HYP.0000000000000257","article-title":"AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and Management of High Blood Pressure in adults: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e020392","DOI":"10.1161\/JAHA.120.020392","article-title":"Impact of uncontrolled hypertension at 3 months after intracerebral hemorrhage","volume":"10","author":"Biffi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.118.312156","article-title":"Treatment of resistant and refractory hypertension","volume":"124","author":"Acelajado","year":"2019","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/ecr.2023.51","article-title":"The global burden of resistant hypertension and potential treatment options","volume":"19","author":"Buso","year":"2024","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hong, D., Stradling, D., Dastur, C.K., Akbari, Y., Groysman, L., Al-Khoury, L., Chen, J., Small, S.L., and Yu, W. (2017). Resistant hypertension after hypertensive intracerebral hemorrhage is associated with more medical interventions and longer hospital stays without affecting outcome. Front. Neurol., 8.","DOI":"10.3389\/fneur.2017.00184"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/CIRCRESAHA.116.303647","article-title":"Genetic and molecular aspects of hypertension","volume":"116","author":"Padmanabhan","year":"2015","journal-title":"Circ. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-023-01430-7","article-title":"Signaling pathways in vascular function and hypertension: Molecular mechanisms and therapeutic interventions","volume":"8","author":"Ma","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, W., Jin, K., Luo, J., Xu, W., Wu, Y., Zhou, J., Wang, Y., Xu, R., Jiao, L., and Wang, T. (2022). NF-\u03baB and its crosstalk with endoplasmic reticulum stress in atherosclerosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.988266"},{"key":"ref_17","unstructured":"Fountain, J.H., and Lappin, S.L. (2023). Physiology, renin angiotensin system. StatPearls, StatPearls Publishing."},{"key":"ref_18","unstructured":"Scott, J.H., Menouar, M.A., and Dunn, R.J. (2023). Physiology, Aldosterone [Internet], StatPearls Publishing."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric oxide-cGMP signaling in hypertension: Current and future options for pharmacotherapy","volume":"76","author":"Golshiri","year":"2020","journal-title":"Hypertension"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/ATVBAHA.106.129254","article-title":"Vascular remodeling: Hemodynamic and biochemical mechanisms underlying Glagov\u2019s phenomenon","volume":"27","author":"Korshunov","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e90777","DOI":"10.1172\/jci.insight.90777","article-title":"Inhibition of neuronal ferroptosis protects hemorrhagic brain","volume":"2","author":"Li","year":"2017","journal-title":"JCI Insight"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/10641963.2020.1783545","article-title":"Study on ferroptosis pathway that operates in hypertensive brain damage","volume":"42","author":"Yang","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/NRR.NRR-D-24-00917","article-title":"NLRP3 inflammasome and gut microbiota-brain axis: A new perspective on white matter injury after intracerebral hemorrhage","volume":"21","author":"Cai","year":"2026","journal-title":"Neural Regen. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2174\/1570159X20666220830115018","article-title":"Secondary White Matter Injury Mediated by Neuroinflammation after Intracerebral Hemorrhage and Promising Therapeutic Strategies of Targeting the NLRP3 Inflammasome","volume":"21","author":"Xiao","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yu, X., Zhou, G., Shao, B., Zhou, H., Xu, C., Yan, F., Wang, L., Chen, G., Li, J., and Fu, X. (2021). Gut Microbiota Dysbiosis Induced by Intracerebral Hemorrhage Aggravates Neuroinflammation in Mice. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.647304"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Luo, J., Chen, Y., Tang, G., Li, Z., Yang, X., Shang, X., Huang, T., Huang, G., Wang, L., and Han, Y. (2022). Gut microbiota composition reflects disease progression, severity and outcome, and dysfunctional immune responses in patients with hypertensive intracerebral hemorrhage. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.869846"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9028969","DOI":"10.1155\/2022\/9028969","article-title":"Exploring the Impact of ACE Inhibition in Immunity and Disease","volume":"2022","author":"Oosthuizen","year":"2022","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2019.10.027","article-title":"MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome","volume":"117","author":"Chen","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bryniarski, P., Nazimek, K., and Marcinkiewicz, J. (2022). Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs-Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031772"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2457770","DOI":"10.1001\/jamanetworkopen.2024.57770","article-title":"Antihypertensive Medication Class and Functional Outcomes After Nonlobar Intracerebral Hemorrhage","volume":"8","author":"Ridha","year":"2025","journal-title":"JAMA Netw. Open."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(08)70069-3","article-title":"Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial","volume":"7","author":"Anderson","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"368","author":"Anderson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","article-title":"Intensive ambulance-delivered blood-pressure reduction in hyperacute stroke","volume":"390","author":"Li","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1093\/ajhp\/zxae156","article-title":"Comparison of clevidipine vs nicardipine in the treatment of hypertensive urgency and emergency in critically ill patients","volume":"81","author":"Johnson","year":"2024","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.ccm.0001101452.89320.e0","article-title":"Comparison Of Nicardipine Vs Clevidipine For Management Of Hypertension In Intracranial Hemorrhage","volume":"53","author":"Caltagirone","year":"2025","journal-title":"Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/NDT.S291624","article-title":"Usage of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in hypertension intracerebral hemorrhage","volume":"17","author":"Zhang","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_40","first-page":"461","article-title":"Using ACE inhibitors appropriately","volume":"66","author":"Bicket","year":"2002","journal-title":"Am. Fam. Physician"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: A multinational cohort study","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"key":"ref_43","unstructured":"McKeever, R.G., Preeti, P., and Richard, J.H. (2024). Calcium channel blockers. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0895-7061(97)00485-8","article-title":"Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release","volume":"11","author":"Bernaud","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jch.13543","article-title":"A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension","volume":"21","author":"Huang","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e075174","DOI":"10.1136\/bmj-2023-075174","article-title":"Thiazide diuretics","volume":"384","author":"Anisman","year":"2024","journal-title":"BMJ"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcvm.2015.00003","article-title":"Mineralocorticoid receptor antagonists therapy in resistant hypertension: Time to implement guidelines!","volume":"2","author":"Maiolino","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_48","unstructured":"Almajid, A.N., Preeti, P., and Manouchkathe, C. (2024). Amiloride. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.2025.5129","article-title":"Spironolactone vs amiloride for resistant hypertension: A randomized clinical trial","volume":"333","author":"Lee","year":"2025","journal-title":"JAMA"},{"key":"ref_50","unstructured":"Farzam, K., and Jan, A. (2025). Beta Blockers. StatPearls [Internet], StatPearls Publishing. Updated 22 August 2023."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","article-title":"Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis","volume":"366","author":"Lindholm","year":"2005","journal-title":"Lancet"},{"key":"ref_52","first-page":"CD002003","article-title":"Beta-blockers for hypertension","volume":"1","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jch.14616","article-title":"Blood pressure lowering effects of \u03b2-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials","volume":"25","author":"Guo","year":"2023","journal-title":"J. Clin. Hypertens."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10072-012-1210-y","article-title":"Is beta-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?","volume":"34","author":"Kalita","year":"2013","journal-title":"Neurol. Sci."},{"key":"ref_55","first-page":"40","article-title":"Role of alpha blockers in hypertension with benign prostatic hyperplasia","volume":"62","author":"Mathur","year":"2014","journal-title":"J. Assoc. Physicians India"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Original Papers. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J. Clin. Hypertens."},{"key":"ref_57","first-page":"CD004643","article-title":"Blood pressure lowering efficacy of alpha blockers for primary hypertension","volume":"8","author":"Heran","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1751-7176.2011.00509.x","article-title":"Central sympatholytic drugs","volume":"13","author":"Vongpatanasin","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/HYPERTENSIONAHA.125.24606","article-title":"Endothelin Antagonism: A New Era for Resistant Hypertension?","volume":"82","author":"Chapman","year":"2025","journal-title":"Hypertension"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1074248415587969","article-title":"Direct vasodilators and sympatholytic agents","volume":"21","author":"McComb","year":"2016","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/HYPERTENSIONAHA.122.19430","article-title":"Novel pharmacological approaches in the treatment of hypertension: A focus on RNA-based therapeutics","volume":"80","author":"Addison","year":"2023","journal-title":"Hypertension"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA interference therapeutic agent for hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_63","first-page":"485","article-title":"Antisense inhibition of angiotensinogen with IONIS-AGT-LRx: Results of phase 1 and phase 2 studies","volume":"6","author":"Morgan","year":"2021","journal-title":"Basic Transl. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","article-title":"Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2, Prevention of angiotensin II\u2013dependent hypertension","volume":"55","author":"Wysocki","year":"2010","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Ren, Y., and Zhang, H. (2023). Emerging role of exosomes in vascular diseases. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1090909"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.124.21728","article-title":"microRNA and Hypertension","volume":"82","author":"He","year":"2025","journal-title":"Hypertension"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1172\/JCI38864","article-title":"Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster","volume":"119","author":"Boettger","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1101\/gad.1842409","article-title":"MiRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury","volume":"23","author":"Xin","year":"2009","journal-title":"Genes Dev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e8046","DOI":"10.15252\/emmm.201708046","article-title":"miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders","volume":"10","author":"Widlansky","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40168-025-02118-6","article-title":"Fecal microbiota transplantation for hypertension: An exploratory, multicenter, randomized, blinded, placebo-controlled trial","volume":"13","author":"Fan","year":"2025","journal-title":"Microbiome"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/HJH.0000000000000515","article-title":"Effects of dietary fibre type on blood pressure: A systematic review and meta-analysis of randomized controlled trials of healthy individuals","volume":"33","author":"Evans","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertension"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Silva, Y.P., Bernardi, A., and Frozza, R.L. (2020). The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00025"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s44161-022-00197-4","article-title":"Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial","volume":"2","author":"Jama","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Raju, M., Perrone, M.A., Alashram, A.R., and Iellamo, F. (2025). Blood Pressure Variability in Hypertension: A Rehabilitation Perspective. J. Cardiovasc. Dev. Dis., 12.","DOI":"10.20944\/preprints202507.0342.v1"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kerr Thompson, T.A., Crowley, M., Doddamani, S., Rai, S., and Salinas, D. (2025). Improving Blood Pressure Control Using Voice-Based AI Agents: A Scalable Approach to Quality Improvement for Seniors. Hypertension, 82.","DOI":"10.1161\/hyp.82.suppl_1.107"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/HYPERTENSIONAHA.112.197780","article-title":"Aerobic exercise reduces blood pressure in resistant hypertension","volume":"60","author":"Dimeo","year":"2012","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11910-023-01256-4","article-title":"Neurocritical care recovery clinics: An idea whose time has come","volume":"23","author":"Salasky","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:44:49Z","timestamp":1773812689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062716"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062716","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}